Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sphenopalatine Ganglion Block for Post Dural Puncture Headache
NCT04401878Completed
- Sponsor
- Zagazig University
- Start
- May 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of lidocaine 10% oropharyngeal spray in post-dural puncture headache (PDPH) (2 arms), sponsored by Zagazig University. Primary endpoint: Numeric Rating Scale for Pain at 24 hours. Started May 2020; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT04401878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04401878.